Navigation Links
EMD Serono Exclusive Supporter of Newly Launched Multiple Sclerosis Resource Centre

ROCKLAND, Mass., Oct. 1, 2013 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is the founding supporter of the newly launched Multiple Sclerosis (MS) Resource Centre website ( developed by Elsevier, B.V. of the Netherlands. EMD Serono helped established the MS Resource Centre through a $250,000 unrestricted grant to Elsevier, B.V. to develop and launch the website, which will provide high quality, balanced and scientifically valid information to health care providers.



"EMD Serono is proud to have provided the necessary foundation for Elsevier to develop this website that aims to provide clinicians with access to the latest literature on multiple sclerosis," said Thorsten Eickenhorst, MD, PhD, MBA, Senior Vice President and Chief Medical Officer at EMD Serono, Inc. "EMD Serono is committed to supporting organizations that invest in the understanding and treatment of multiple sclerosis, and share our goal of improving patient care."

The MS Resource Centre is a medical education platform for healthcare providers hosted by Elsevier's new peer-reviewed journal, Multiple Sclerosis and Related Disorders ( This website will afford the MS community numerous benefits, including access to taped lectures, video interviews with leaders in the field, a congress planner and key articles reporting on breakthrough findings by highly regarded authors.  Timothy Vartanian, MD, PhD, Professor at the Brain and Mind Research Institute and the Department of Neurology, Weill Cornell Medical College, Cornell University is the Editor of the Resource Center.

The site will be launched at the ECTRIMS 2013 conference, October 2 – 5, in Copenhagen, Denmark.  For more information, congress delegates should stop by the Elsevier Exhibit Booth at ECTRIMS.

About EMD Serono, Inc.
EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is a leader in the US biopharmaceutical arena, integrating cutting-edge science with unparalleled patient support systems to improve people's lives. The company has strong market positions in neurodegenerative diseases, endocrinology and in reproductive health. In addition, EMD Serono is growing its expertise and presence in the area of oncology, with more than 15 projects currently in development. With a clear focus on the patient and a leadership presence in the biopharmaceutical industry, EMD Serono's US footprint continues to grow, with approximately 1,000 employees around the country and fully integrated commercial, clinical and research operations in the company's home state of Massachusetts.

For more information, please visit 

About Merck KGaA
Merck is a leading pharmaceutical, chemical and life science company with total revenues of € 11.2 billion in 2012, a history that began in 1668, and a future shaped by approx. 38,000 employees in 66 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

For more information, please visit or

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Merck Serono progresse à la huitième place dans le classement Access to Medicine Index
2. EMD Serono Expands the Grant for Fertility Innovation (GFI) Program to Include U.S. Investigators
3. Alliqua Becomes Exclusive Distributor of sorbion-Branded Wound Products in the Americas Through Agreement with Carolon
4. BioLife Solutions and SAVSU Technologies Announce Exclusive Distribution Agreement
5. B. Riley Exclusive Financial Advisor to Mirth Corporation in Connection with its Corporate Sale to Quality Systems, Inc.
6. Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm
7. Sanofi US and POZEN Sign Exclusive License Agreement for the Commercialization of PA8140/PA32540 Tablets in the U.S.
8. Eisai Inc. Announces Non-Exclusive Licensing Agreement with Generic Drug Manufacturer to Provide Generic Version of donepezil HCl 23 mg
9. Digirad Signs Exclusive International Distribution Agreement with Dilon Diagnostics
10. GUARDaHEART to Host Exclusive Event focused on Targeting Heart Disease in Celebration of the World Heart Day Mission
11. BSI Offers Medical Device Manufacturers Exclusive Access to Global Panel of Experts in 3 Key Cities
Post Your Comments:
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... , June 23, 2016 , ... Thursday, July 7, 2016 , , , , LOCATION: , ... , , , , EXPERT PANELISTS:  , , , Frost ... Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh ... The global pharmaceutical industry is witnessing an exceptional era. Several ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):